These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 10876746

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Relative bioavailability of ondansetron 8-mg oral tablets versus two extemporaneous 16-mg suppositories: formulation and gender differences.
    Jann MW, ZumBrunnen TL, Tenjarla SN, Ward ES, Weidler DJ.
    Pharmacotherapy; 1998; 18(2):288-94. PubMed ID: 9545148
    [Abstract] [Full Text] [Related]

  • 3. Pharmacokinetic profile and clinical efficacy of a once-daily ondansetron suppository in cyclophosphamide-induced emesis: a double blind comparative study with ondansetron tablets.
    de Wit R, Beijnen JH, van Tellingen O, Schellens JH, de Boer-Dennert M, Verweij J.
    Br J Cancer; 1996 Jul; 74(2):323-6. PubMed ID: 8688345
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Relative bioavailability of an extemporaneous ondansetron 4-mg capsule formulation versus solution.
    Lam YW, Javors MA, Ait-Daoud N, Roache JD, Johnson BA.
    Pharmacotherapy; 2004 Apr; 24(4):477-81. PubMed ID: 15098801
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Comparative bioavailability of a cisapride suppository and tablet formulation in healthy volunteers.
    Hedner T, Hedner J, Gelin-Friberg A, Huang ML, Van de Poel S, Woestenborghs R, Van Peer A, Heykants J.
    Eur J Clin Pharmacol; 1990 Apr; 38(6):629-31. PubMed ID: 2373139
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Pharmacokinetics of tramadol and bioavailability of enteral tramadol formulations. 3rd Communication: suppositories.
    Lintz W, Barth H, Osterloh G, Schmidt-Böthelt E.
    Arzneimittelforschung; 1998 Sep; 48(9):889-99. PubMed ID: 9793614
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
    Chen C, Bujanover S, Kareht S, Rapoport AM.
    Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
    [Abstract] [Full Text] [Related]

  • 15. Oral, subcutaneous, and intravenous pharmacokinetics of ondansetron in healthy cats.
    Quimby JM, Lake RC, Hansen RJ, Lunghofer PJ, Gustafson DL.
    J Vet Pharmacol Ther; 2014 Aug; 37(4):348-53. PubMed ID: 24330064
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Pharmacokinetics and bioavailability studies of generic ondansetron, and the innovator preparation, in healthy Thai male volunteers.
    Rojanasthien N, Manorot M, Kumsorn B, Nawoot S, Teekachunhatean S, Sangdee C, Apisariyakul A.
    J Med Assoc Thai; 1999 Jul; 82(7):713-20. PubMed ID: 10511774
    [Abstract] [Full Text] [Related]

  • 18. Pharmacokinetics and bioequivalence testing of generic ondansetron preparations in healthy Thai male volunteers.
    Rojanasthien N, Manorot M, Kumsorn B.
    Int J Clin Pharmacol Ther; 1999 Nov; 37(11):548-54. PubMed ID: 10584976
    [Abstract] [Full Text] [Related]

  • 19. Bioequivalence assay between orally disintegrating and conventional tablet formulations in healthy volunteers.
    Armando YP, Schramm SG, Silva Mde F, Kano EK, Koono EE, Porta V, Serra CH.
    Int J Pharm; 2009 Jan 21; 366(1-2):149-53. PubMed ID: 18848869
    [Abstract] [Full Text] [Related]

  • 20. Bioavailability of repaglinide, a novel antidiabetic agent, administered orally in tablet or solution form or intravenously in healthy male volunteers.
    Hatorp V, Oliver S, Su CA.
    Int J Clin Pharmacol Ther; 1998 Dec 21; 36(12):636-41. PubMed ID: 9877000
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.